Literature DB >> 22613861

Phototoxic and photoallergic cutaneous drug reactions.

Martin Glatz1, Günther F L Hofbauer.   

Abstract

A variety of topical and systemic drugs can induce cutaneous photosensitive reactions. These drugs and their metabolites accumulate in the skin and increase photosensitivity of the skin typically in the UVA spectrum of light. Concerning the underlying biochemical mechanisms and the phenotype of reactions, photosensitivity can be divided into phototoxic and photoallergic reactions. In phototoxic reactions, often highly reactive oxygen molecules are formed that induce tissue damage. Skin changes resemble sunburn and develop within hours after incubation with the drug together with sunlight. In contrast, photoallergic reactions are type IV hypersensitivity reactions, and therefore resemble eczema. They usually develop within days and are less common than phototoxic reactions. Diagnosis is based on a synopsis of complete history, clinical examination, phototesting for minimal phototoxicity dose, patch testing including photopatch tests, and histopathology. Mainstays of treatment are the withdrawal of the culprit drug, and avoidance of sunlight by wearing protective clothing and broadband sunscreens with UVA filters.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613861     DOI: 10.1159/000335630

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  10 in total

1.  Environmental factors associated with disease flare in juvenile and adult dermatomyositis.

Authors:  Gulnara Mamyrova; Lisa G Rider; Alison Ehrlich; Olcay Jones; Lauren M Pachman; Robert Nickeson; Lisa G Criscone-Schreiber; Lawrence K Jung; Frederick W Miller; James D Katz
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

Review 2.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

3.  Pterin-lysine photoadduct: a potential candidate for photoallergy.

Authors:  Jesuan J Farías; Paloma Lizondo-Aranda; Andrés H Thomas; Virginie Lhiaubet-Vallet; M Laura Dántola
Journal:  Photochem Photobiol Sci       Date:  2022-06-06       Impact factor: 4.328

4.  The Assessment of Meloxicam Phototoxicity in Human Normal Skin Cells: In Vitro Studies on Dermal Fibroblasts and Epidermal Melanocytes.

Authors:  Marta Karkoszka; Jakub Rok; Klaudia Banach; Justyna Kowalska; Zuzanna Rzepka; Dorota Wrześniok
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

5.  Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort.

Authors:  Emily McDonald; D Michal Freedman; Bruce H Alexander; Michele M Doody; Margaret A Tucker; Martha S Linet; Elizabeth K Cahoon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

6.  Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma.

Authors:  Yuri Sakaguchi; Takaya Komori; Megumi Aoki; Atsushi Otsuka; Kenji Kabashima; Shigeto Matsushita
Journal:  Acta Derm Venereol       Date:  2020-11-26       Impact factor: 3.875

Review 7.  Ketoprofen-induced photoallergic dermatitis.

Authors:  Tiffany Yvonne Loh; Philip R Cohen
Journal:  Indian J Med Res       Date:  2016-12       Impact factor: 2.375

Review 8.  Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences.

Authors:  Georg Amun Hofmann; Benedikt Weber
Journal:  J Dtsch Dermatol Ges       Date:  2021-01       Impact factor: 5.584

9.  A phototoxic drug reaction due to topical NSAIDs.

Authors:  Jakob Lillemoen Drivenes; Martin Berg-Jensen; Anette Bygum
Journal:  Clin Case Rep       Date:  2022-01-20

10.  Biotic acts of antibiotics.

Authors:  Rustam I Aminov
Journal:  Front Microbiol       Date:  2013-08-19       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.